Home > Insider Trading > Filing (0001209191-22-048167)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1637715	Reneo Pharmaceuticals Inc.	RPHM	Pharmaceutical Preparations (2834)	472309515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1854179	Michael Cruse	C/O Reneo Pharmaceuticals, Inc. 18575 Jamboree Road, Suite 275-S Irvine CA 92612	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-29	83	$3.24	30,783	No	4	P	Direct
Common Stock	Acquisiton	2022-08-29	1,140	$3.24	1,140	No	4	P	Indirect	by Trust
Common Stock	Acquisiton	2022-08-30	975	$3.16	31,758	No	4	P	Direct
Common Stock	Acquisiton	2022-08-30	1,845	$3.19	2,985	No	4	P	Indirect	by Trust
Common Stock	Acquisiton	2022-08-31	3,212	$3.21	6,197	No	4	P	Indirect	by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	by Trust
No	4	P	Direct
No	4	P	Indirect	by Trust
No	4	P	Indirect	by Trust

Footnotes

Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on June 8, 2022.
By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust.
The weighted average purchase price for the transaction was $3.16. The shares were purchased at a range of prices between $3.11 and $3.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
The weighted average purchase price for the transaction was $3.1938. The shares were purchased at a range of prices between $3.16 and $3.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
The weighted average purchase price for the transaction was $3.209. The shares were purchased at a range of prices between $3.19 and $3.29. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.